AESOP TECHNOLOGY
  • DxPrime
  • DxCode
  • Medigator for Oncology
  • RxPrime
  • Research
  • AESOP Talks
  • News
  • About
  • EN/CH

Evidence-Based AI Navigation ​​for

Informed Decisions on Cancer Medication

Request More ​Information

Mastering Trends in Cancer Treatment Applications

Ensure your cancer care plan adapts to changes

Staying updated with the latest developments in cancer treatment can be challenging. Each therapy is supported by hundreds of publications from ongoing clinical trials, updated FDA indications, and evolving clinical guidelines. Medigator for Oncology provides evidence-based recommendations for chemotherapy, immunotherapy, and combination therapies, helping physicians keep up with rapid changes in information.


Access organized information based on
the latest evidence and clinical guidelines


Tracks and predicts cancer progression,
​prognosis, and treatment efficacy

More feasible,
more personalized

Cancer treatment is complex, and patients often struggle to maintain long-term therapy due to side effects and costs. Medigator for Oncology assists oncologists in predicting and managing disease progression. It helps evaluate the appropriate timing for adjusting or discontinuing treatment and facilitates discussions about potential next steps with patients. This ensures timely adjustments to treatment plans, leading to optimal outcomes and an improved quality of life.


Proactively analyze medical records
to recommend chemo-, immuno-,
​and combination therapies for all cancer stages


Follow-up on
treatment adherence
and medication management


Request More
​Information

Submit
AESOP TECHNOLOGY
[email protected]
​Privacy Policy
© AESOP Technology 2025
  • DxPrime
  • DxCode
  • Medigator for Oncology
  • RxPrime
  • Research
  • AESOP Talks
  • News
  • About
  • EN/CH